Neurocrine Biosciences Announces Initiation of Phase II Clinical
PR Newswire - collaboration between Neurocrine and GlaxoSmithKline (GSK), GSK has initiated Phase II "proof of concept" clinical trials with a lead Corticotropin Releasing Factor R1 (CRF1) receptor antagonist compound for two indications, social anxiety disorder
Source: sev.prnewswire.com
Gadget Lab: Sweet Cyborg Headset
Wired - In this week's Lab, we're singing the praises of a laptop capable of giving you social anxiety disorder, a cybernetically inspired hands-free set, and a DDR machine that'll have you dancing like no one's watching. Got your own wacky hack of musical
Source: www.wired.com
Click here for more information about is it normal for anxiety disorder
<< Home